The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria
| Autor: | Roland Kaufmann, Bernhard F. Gibbs, Falk Ochsendorf, Wolf-Henning Boehncke, Thomas Matthias Zollner, Ralf Ludwig |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Adult
Male Anti-Inflammatory Agents Non-Steroidal/*therapeutic use medicine.medical_specialty Pathology Urticaria medicine.medical_treatment Dermatology Cyclooxygenase Inhibitors/*therapeutic use Histamine Release Gastroenterology Lactones Internal medicine Immunopathology Humans Medicine Cyclooxygenase Inhibitors Sulfones Rofecoxib Chemotherapy biology business.industry Lactones/*therapeutic use Anti-Inflammatory Agents Non-Steroidal Histamine Release/drug effects Middle Aged Enzyme inhibitor Chronic Disease Urticaria/*drug therapy biology.protein Female Cyclooxygenase Chronic idiopathic urticaria business medicine.drug |
| Zdroj: | British Journal of Dermatology, Vol. 148, No 3 (2003) pp. 604-606 |
| ISSN: | 1365-2133 0007-0963 |
| DOI: | 10.1046/j.1365-2133.2003.05209_12.x |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text